XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) Fundamental Analysis & Valuation

NASDAQ:XOMAO • US98419J4040

Current stock price

25.4278 USD
-0.11 (-0.44%)
Last:

This XOMAO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. XOMAO Profitability Analysis

1.1 Basic Checks

  • XOMAO had positive earnings in the past year.
  • In the past year XOMAO had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: XOMAO reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: XOMAO reported negative operating cash flow in multiple years.
XOMAO Yearly Net Income VS EBIT VS OCF VS FCFXOMAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M

1.2 Ratios

  • XOMAO has a better Return On Assets (6.80%) than 92.05% of its industry peers.
  • Looking at the Return On Equity, with a value of 17.83%, XOMAO belongs to the top of the industry, outperforming 94.57% of the companies in the same industry.
  • XOMAO's Return On Invested Capital of 3.78% is amongst the best of the industry. XOMAO outperforms 89.53% of its industry peers.
Industry RankSector Rank
ROA 6.8%
ROE 17.83%
ROIC 3.78%
ROA(3y)-7.23%
ROA(5y)-6.6%
ROE(3y)-19.31%
ROE(5y)-14.1%
ROIC(3y)N/A
ROIC(5y)N/A
XOMAO Yearly ROA, ROE, ROICXOMAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800 1K

1.3 Margins

  • With an excellent Profit Margin value of 35.54%, XOMAO belongs to the best of the industry, outperforming 96.12% of the companies in the same industry.
  • In the last couple of years the Profit Margin of XOMAO has grown nicely.
  • Looking at the Operating Margin, with a value of 21.83%, XOMAO belongs to the top of the industry, outperforming 93.99% of the companies in the same industry.
  • XOMAO's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.83%
PM (TTM) 35.54%
GM N/A
OM growth 3YN/A
OM growth 5Y-12.38%
PM growth 3YN/A
PM growth 5Y2.98%
GM growth 3YN/A
GM growth 5YN/A
XOMAO Yearly Profit, Operating, Gross MarginsXOMAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. XOMAO Health Analysis

2.1 Basic Checks

  • XOMAO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, XOMAO has less shares outstanding
  • XOMAO has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, XOMAO has an improved debt to assets ratio.
XOMAO Yearly Shares OutstandingXOMAO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
XOMAO Yearly Total Debt VS Total AssetsXOMAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -4.50, we must say that XOMAO is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -4.50, XOMAO is doing worse than 62.98% of the companies in the same industry.
  • The Debt to FCF ratio of XOMAO is 37.96, which is on the high side as it means it would take XOMAO, 37.96 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of XOMAO (37.96) is better than 89.15% of its industry peers.
  • XOMAO has a Debt/Equity ratio of 0.93. This is a neutral value indicating XOMAO is somewhat dependend on debt financing.
  • XOMAO has a worse Debt to Equity ratio (0.93) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 37.96
Altman-Z -4.5
ROIC/WACC0.37
WACC10.33%
XOMAO Yearly LT Debt VS Equity VS FCFXOMAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.37 indicates that XOMAO has no problem at all paying its short term obligations.
  • XOMAO has a Current ratio of 3.37. This is comparable to the rest of the industry: XOMAO outperforms 41.28% of its industry peers.
  • XOMAO has a Quick Ratio of 3.37. This indicates that XOMAO is financially healthy and has no problem in meeting its short term obligations.
  • XOMAO has a Quick ratio (3.37) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
XOMAO Yearly Current Assets VS Current LiabilitesXOMAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. XOMAO Growth Analysis

3.1 Past

  • XOMAO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 170.87%, which is quite impressive.
  • Measured over the past years, XOMAO shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.56% on average per year.
  • Looking at the last year, XOMAO shows a very strong growth in Revenue. The Revenue has grown by 73.96%.
  • XOMAO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.15% yearly.
EPS 1Y (TTM)170.87%
EPS 3YN/A
EPS 5Y29.56%
EPS Q2Q%157.78%
Revenue 1Y (TTM)73.96%
Revenue growth 3Y105.26%
Revenue growth 5Y12.15%
Sales Q2Q%57.87%

3.2 Future

  • Based on estimates for the next years, XOMAO will show a small growth in Earnings Per Share. The EPS will grow by 7.92% on average per year.
  • XOMAO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.23% yearly.
EPS Next Y-66.47%
EPS Next 2Y-30.77%
EPS Next 3Y7.92%
EPS Next 5YN/A
Revenue Next Year28.91%
Revenue Next 2Y11.05%
Revenue Next 3Y18.11%
Revenue Next 5Y31.23%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XOMAO Yearly Revenue VS EstimatesXOMAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
XOMAO Yearly EPS VS EstimatesXOMAO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4 -6 -8 -10

More info and screens

Find the best growth stocksShow best growing peers

5

4. XOMAO Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.42, XOMAO is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of XOMAO indicates a rather cheap valuation: XOMAO is cheaper than 94.19% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, XOMAO is valued a bit cheaper.
  • XOMAO is valuated quite expensively with a Price/Forward Earnings ratio of 51.94.
  • Based on the Price/Forward Earnings ratio, XOMAO is valued cheaply inside the industry as 89.92% of the companies are valued more expensively.
  • XOMAO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.24.
Industry RankSector Rank
PE 17.42
Fwd PE 51.94
XOMAO Price Earnings VS Forward Price EarningsXOMAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • XOMAO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. XOMAO is cheaper than 92.05% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, XOMAO is valued cheaper than 90.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 105.57
EV/EBITDA 22.88
XOMAO Per share dataXOMAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • XOMAO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.59
EPS Next 2Y-30.77%
EPS Next 3Y7.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. XOMAO Dividend Analysis

5.1 Amount

  • XOMAO has a Yearly Dividend Yield of 8.23%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.71, XOMAO pays a better dividend. On top of this XOMAO pays more dividend than 99.61% of the companies listed in the same industry.
  • XOMAO's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 8.23%

5.2 History

  • XOMAO has been paying a dividend for over 5 years, so it has already some track record.
  • XOMAO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
XOMAO Yearly Dividends per shareXOMAO Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 29.53% of the earnings are spent on dividend by XOMAO. This is a low number and sustainable payout ratio.
DP29.53%
EPS Next 2Y-30.77%
EPS Next 3Y7.92%
XOMAO Yearly Income VS Free CF VS DividendXOMAO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M
XOMAO Dividend Payout.XOMAO Dividend Payout, showing the Payout Ratio.XOMAO Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

XOMAO Fundamentals: All Metrics, Ratios and Statistics

XOMA ROYALTY CORP - XOMA 8 3/8 PERP

NASDAQ:XOMAO (4/24/2026, 8:15:09 PM)

25.4278

-0.11 (-0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-18
Earnings (Next)04-30
Inst Owners73.82%
Inst Owner ChangeN/A
Ins Owners3.97%
Ins Owner ChangeN/A
Market Cap303.10M
Revenue(TTM)52.15M
Net Income(TTM)18.53M
Analysts81.82
Price Target44.2 (73.83%)
Short Float %0.03%
Short Ratio1.51
Dividend
Industry RankSector Rank
Dividend Yield 8.23%
Yearly Dividend0.46
Dividend Growth(5Y)N/A
DP29.53%
Div Incr Years0
Div Non Decr Years4
Ex-Date04-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1040.07%
Min EPS beat(2)264.45%
Max EPS beat(2)1815.69%
EPS beat(4)4
Avg EPS beat(4)623.83%
Min EPS beat(4)119.7%
Max EPS beat(4)1815.69%
EPS beat(8)5
Avg EPS beat(8)324.56%
EPS beat(12)6
Avg EPS beat(12)211.09%
EPS beat(16)7
Avg EPS beat(16)137.03%
Revenue beat(2)1
Avg Revenue beat(2)1.01%
Min Revenue beat(2)-20.06%
Max Revenue beat(2)22.07%
Revenue beat(4)3
Avg Revenue beat(4)38.88%
Min Revenue beat(4)-20.06%
Max Revenue beat(4)120.82%
Revenue beat(8)6
Avg Revenue beat(8)25.22%
Revenue beat(12)7
Avg Revenue beat(12)14.07%
Revenue beat(16)8
Avg Revenue beat(16)2.21%
PT rev (1m)-33.04%
PT rev (3m)-29.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)126.32%
EPS NY rev (1m)55.72%
EPS NY rev (3m)55.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.32%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE 17.42
Fwd PE 51.94
P/S 5.81
P/FCF 105.57
P/OCF 105.57
P/B 2.92
P/tB 5.12
EV/EBITDA 22.88
EPS(TTM)1.46
EY5.74%
EPS(NY)0.49
Fwd EY1.93%
FCF(TTM)0.24
FCFY0.95%
OCF(TTM)0.24
OCFY0.95%
SpS4.37
BVpS8.72
TBVpS4.97
PEG (NY)N/A
PEG (5Y)0.59
Graham Number16.9263 (-33.43%)
Profitability
Industry RankSector Rank
ROA 6.8%
ROE 17.83%
ROCE 4.79%
ROIC 3.78%
ROICexc 5.82%
ROICexgc 8.19%
OM 21.83%
PM (TTM) 35.54%
GM N/A
FCFM 5.51%
ROA(3y)-7.23%
ROA(5y)-6.6%
ROE(3y)-19.31%
ROE(5y)-14.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-24.81%
ROICexc growth 3YN/A
ROICexc growth 5Y-29.78%
OM growth 3YN/A
OM growth 5Y-12.38%
PM growth 3YN/A
PM growth 5Y2.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 37.96
Debt/EBITDA 6.72
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 0.96
Cash Conversion 20%
Profit Quality 15.49%
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z -4.5
F-Score7
WACC10.33%
ROIC/WACC0.37
Cap/Depr(3y)3117.3%
Cap/Depr(5y)4643.1%
Cap/Sales(3y)23.75%
Cap/Sales(5y)64.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)170.87%
EPS 3YN/A
EPS 5Y29.56%
EPS Q2Q%157.78%
EPS Next Y-66.47%
EPS Next 2Y-30.77%
EPS Next 3Y7.92%
EPS Next 5YN/A
Revenue 1Y (TTM)73.96%
Revenue growth 3Y105.26%
Revenue growth 5Y12.15%
Sales Q2Q%57.87%
Revenue Next Year28.91%
Revenue Next 2Y11.05%
Revenue Next 3Y18.11%
Revenue Next 5Y31.23%
EBIT growth 1Y191.25%
EBIT growth 3YN/A
EBIT growth 5Y-1.73%
EBIT Next Year135.95%
EBIT Next 3Y94.59%
EBIT Next 5YN/A
FCF growth 1Y108.46%
FCF growth 3YN/A
FCF growth 5Y-22.21%
OCF growth 1Y120.88%
OCF growth 3YN/A
OCF growth 5Y-22.23%

XOMA ROYALTY CORP - XOMA 8 3/8 PERP / XOMAO Fundamental Analysis FAQ

What is the ChartMill fundamental rating of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) stock?

ChartMill assigns a fundamental rating of 6 / 10 to XOMAO.


What is the valuation status for XOMAO stock?

ChartMill assigns a valuation rating of 5 / 10 to XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO). This can be considered as Fairly Valued.


What is the profitability of XOMAO stock?

XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) has a profitability rating of 6 / 10.


Can you provide the financial health for XOMAO stock?

The financial health rating of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) is 5 / 10.


How sustainable is the dividend of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) stock?

The dividend rating of XOMA ROYALTY CORP - XOMA 8 3/8 PERP (XOMAO) is 6 / 10 and the dividend payout ratio is 29.53%.